1. Acute cardiomyopathy following a single dose of doxorubicin in a patient with adult T-Cell leukemia/lymphoma. (June 2021) Authors: Farina, Kyle; Kalac, Matko; Kim, Sara Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 4(2021) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma. (16th December 2016) Authors: Kalac, Matko; Lue, Jennifer K.; Lichtenstein, Emily; Turenne, Ithamar; Rojas, Celeste; Amengual, Jennifer E.; Sawas, Ahmed; Deng, Changchun; Mapara, Markus Y.; Connors, Joseph M.; Kuruvilla, John; O'Connor, Owen A. Journal: British journal of haematology Issue: Volume 180:Number 5(2018) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial. Issue 2 (February 2018) Authors: O'Connor, Owen A; Lue, Jennifer K; Sawas, Ahmed; Amengual, Jennifer E; Deng, Changchun; Kalac, Matko; Falchi, Lorenzo; Marchi, Enrica; Turenne, Ithamar; Lichtenstein, Renee; Rojas, Celeste; Francescone, Mark; Schwartz, Lawrence; Cheng, Bin; Savage, Kerry J; Villa, Diego; Crump, Michael; Prica, An... Journal: Lancet oncology Issue: Volume 19:Issue 2(2018) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial. Issue 2 (February 2018) Authors: O'Connor, Owen A; Lue, Jennifer K; Sawas, Ahmed; Amengual, Jennifer E; Deng, Changchun; Kalac, Matko; Falchi, Lorenzo; Marchi, Enrica; Turenne, Ithamar; Lichtenstein, Renee; Rojas, Celeste; Francescone, Mark; Schwartz, Lawrence; Cheng, Bin; Savage, Kerry J; Villa, Diego; Crump, Michael; Prica, An... Journal: Lancet oncology Issue: Volume 19:Issue 2(2018) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma. (20th July 2015) Authors: Marchi, Enrica; Zullo, Kelly M.; Amengual, Jennifer E.; Kalac, Matko; Bongero, Danielle; McIntosh, Christine M.; Fogli, Laura K.; Rossi, Maura; Zinzani, Pier L.; Pileri, Stefano A.; Piccaluga, Pier P.; Fuligni, Fabio; Scotto, Luigi; O'Connor, Owen A. Journal: British journal of haematology Issue: Volume 171:Number 2(2015:Oct.) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗